Pain, Postoperative
Conditions
Brief summary
To better determine whether parasternal subpectoral plane blocks (PSPB) infusing bupivacaine for midline sternotomy decreases opioid consumption and pain scores. This is a prospective, blinded randomized controlled trial with 2 arms. 1 arm is the saline control arm, PSPB catheters will be placed with saline and continue to infuse saline. The other arm is bupivacaine study arm, PSPB catheters will be placed with bupivacaine and continue to infuse the local anesthetic.
Detailed description
Subjects will be randomized to receive PSPB catheters infusing either bupivacaine or saline. Randomization will be achieved using a computer-generated randomization scheme. The surgeon, nurse, anesthetist and patient will be blinded. The investigational drug service will prepare blinded solutions (bupivacaine 0.2% or saline syringes) for performance of the block. They will also prepare bags (either bupivacaine 0.125% or saline) to be infused through the catheter. Following skin closure, but before removal of the surgical drapes, regional anesthesiologists will scrub in, gown and perform the placement of PSPB catheters under strict surgical aseptic technique. Real-time ultrasound (US) imaging will be used to visualize the pectoralis major muscle and its corresponding rib cartilages, and a needle/introducer sheath will be guided parasternally into the fascial plane. The needle will be advanced in the plane, hydro-dissecting with 30 mL of bupivacaine 0.2% in the study group or 30 mL of saline in the control group per side. Following hydro-dissection, a 5 in. multiport catheter will be inserted via the sheath, and the catheter will be secured following US confirmation of appropriate catheter position. This procedure will then be repeated on the other side. After completion of bilateral PSPB catheters, patients will remain intubated and be transferred to the CSICU on a sedation regimen at the discretion of the intraoperative anesthesia team. Upon dropping off to the ICU, each catheter will be attached to a programmable pump infusing plain bupivacaine 0.125% at 10 mL/hr or saline infusing at 10 mL/hr. Once again, the solution to be infused postoperatively will be prepared by pharmacy and blinded from the patient, nurse, and postoperative pain service providers.
Interventions
PROCEDUREParasternal Subpectoral Plane Block
Nerve block catheter inserted into plane between rib cartilages and pectoralis muscle.
Sponsors
Brigham and Women's Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Masking description
Saline and Bupivacaine are both clear fluids and look identical. Research pharmacy will prepare blinded solutions for use in study.
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
1. Male or Female 2. Aged 18 - 80 years 3. scheduled for primary elective cardiac surgery via median sternotomy 4. willingness to undergo psychosocial testing 5. willingness to participate in long-term follow up 6. willingness to be randomized to receive local anesthetic or saline infusion through PSPB catheters 7. access to an email and computer
Exclusion criteria
1. Allergy to opioids 2. allergy to bupivacaine 3. emergency surgery 4. unable to provide informed consent 5. weight less than 50kg
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Opioid Consumption | 2 days | Cumulative opioid consumption on post-operative day 1 and 2 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Persistent Postoperative Pain scores | Measured at 1 year | Persistent midline sternotomy pain, on a numerical rating scale (NRS) 0-10 |
| Pain and patient characteristics | 1 year | Whether there is a correlation between development of persistent post-sternotomy pain and psychosocial/psychophysical characteristics. Will be ascertained from a variety of questionnaires (i.e. brief pain index, brief symptom inventory, coping strategies, fibromyalgianess, pain catastrophizing scale, positive and negative affect scale, PROMIS anxiety short form (SF), PROMIS depression SF, PROMIS sleep disturbance SF |
| Incidence of arrhythmia | Hospital stay, an average of 5 days | Whether active bupivacaine group has lower incidence of arrythmia versus saline control group. And whether this correlates to a certain plasma bupivacine level |
| Time to extubation | Post-operative day 1 | From arrival time to ICU to extubation |
| Acute Postoperative Pain scores | through initial hospital stay, an average of 5 days | At rest and activity, on a numerical rating scale (NRS) 0-10 |
| Length of hospital stay | From arrival to ICU to discharge from hospital, up to 5 days | When patients are deemed ready to be discharged from hospital |
| Incidence of delirium | Time in ICU to discharge to floor, up to 3 days | Assessed using CAM-ICU |
| Time to first opioid administration after extubation | Extubation to first opioid administration, up to 3 days | When patient first requests opioid after extubation |
| Length of ICU stay | From arrival to ICU to discharge to floor, up to 5 days | When patients are deemed ready to be discharged from ICU |
Outcome results
None listed